HomeProducts › Urology › Bladmir S 50mg Tablet

Bladmir S 50mg Tablet

Salt Composition: MIRABEGRON,SOLIFENACIN

₹450.00₹562.03

Inclusive of all taxes

Bladmir S 50mg Tablet

Categories: Urology

Conditions: Others

Product Introduction

Bladmir S 50mg Tablet contains two active ingredients: Mirabegron and Solifenacin. It belongs to the family of Beta 3-adrenoceptor agonists and muscarinic receptor antagonists. This medicine reduces the activity and symptoms associated with an overactive bladder, such as urgency incontinence (inability to control bladder emptying), sudden urination urges, and increased urinary frequency. This medicine is not advised for use in children under 18 years of age. Bladmir S 50mg Tablet should not be taken if you have allergies to Mirabegron, Solifenacin, or if you have high uncontrolled blood pressure. Before starting treatment, inform your doctor if you have trouble emptying your bladder (urinary retention) or if you are taking specific medications for HIV, fungal or bacterial infections, or anticholinergic medicines. Avoid taking this medicine if you have a severe stomach or bowel condition such as toxic megacolon, muscle disease (myasthenia gravis), or glaucoma with progressive vision loss. It is recommended not to use this medicine if you are undergoing kidney dialysis or if you have severe liver disease. Do not take Bladmir S 50mg Tablet if you are pregnant, planning to get pregnant, or breastfeeding. Before starting treatment, notify your doctor if you have liver or kidney problems. Your doctor may adjust your dose in such conditions. Also, inform your doctor if you have any heart conditions, such as abnormal ECG (QT prolongation) or are taking medications that may cause it. Report to your doctor if you have constipation, stomach tear (hiatus hernia), heartburn, or nervous disorder (autonomic neuropathy).

Uses

Treatment of overactive bladder (OAB) symptoms. It helps to control uncontrollable bladder emptying (urgency incontinence). Reduce sudden urges to urinate. Reduce frequent urination

How it works

Bladmir S 50mg Tablet works together to improve bladder function. Mirabegron stimulates beta-3 adrenergic receptors, leading to the relaxation of bladder muscles, increased bladder capacity, and reduced urgency and frequency of urination. Solifenacin, on the other hand, blocks muscarinic receptors, relaxing the bladder muscles, reducing contractions, and increasing bladder capacity. This combined action helps improve overall bladder control and reduce urinary symptoms.

How to Use

Take the Bladmir S 50mg Tablet as your physician advises. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Irregular heartbeat Sudden or throbbing headache Angioedema ( swelling of the face, mouth, or throat) Elevated blood pressure Common Increased heart rate Nausea Constipation Diarrhea Dizziness Urinary tract infection Abdominal pain Heartburn Burping Blurred vision

Expert Tips

Patients with liver, heart, and kidney disorders should take Bladmir S 50mg Tablet cautiously and inform the doctor about all the underlying medical conditions and medications that you consume. Avoid using this medication if you are intolerant to lactose sugar. Do not stop Bladmir S 50mg Tablet until your doctor advises. Do not double-dose the medicine to make up for a forgotten dose. Notify your doctor if you experience any serious side effects. Your medical professional will inform you if you need any dose adjustments. Contact your doctor for more information.

References

  1. Astellas Pharma Ltd, Electronic Medicines Compendium (EMC), [Revised on December 2022] [Accessed on 6th June 2023], Mirabegron + Solifenacin-TAB PL-Patient United Kingdom (Great Britain) en - TW366830 (medicines.org.uk)
  2. Astellas Pharma US, Inc; [Revised on March 2021] [Accessed on 6th June 2023], label (fda.gov)
  3. Astellas Pharma Ltd, Electronic medicines compendium (EMC), [Revised on Dec 2022] [ Accessed on 20th June 2023], https://www.medicines.org.uk/emc/files/pil.5559.pdf
  4. GlaxoSmithKline, US Food and Drug Administration, [Revised on April 2010] [ Accessed on 20th June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021518s008lbl.pdf
  5. Goodman & Gilman'sGilman's, The Pharmacological Basis of Therapeutics, Muscarinic receptor agonists and antagonists, 12th edition, 2011, 231.
  6. J. Goddard, A.N. Turner, Kidney, and urinary tract disease, Davidson’s Principles and Practice of Medicine, 22nd Edition, 2014, 461-523.

Safety Advice

Pregnancy: unsafe Bladmir S 50mg Tablet is unsafe during pregnancy as it may harm the developing baby. Before starting the treatment, inform your doctor if you are pregnant or planning to get pregnant.

Lungs: safe It is unknown whether Bladmir S 50mg Tablet is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.

Breastfeeding: unsafe It is unsafe to use Bladmir S 50mg Tablet during breastfeeding because the medicine may pass into breast milk. Consult your doctor for advice. Inform your doctor if you are breastfeeding.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS